Segall Bryant & Hamill LLC Buys New Shares in Corteva, Inc. $CTVA

Segall Bryant & Hamill LLC purchased a new position in Corteva, Inc. (NYSE:CTVA) during the 1st quarter, Holdings Channel reports. The firm purchased 11,330 shares of the company’s stock, valued at approximately $891,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Brighton Jones LLC raised its holdings in Corteva by 307.2% in the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after acquiring an additional 11,760 shares in the last quarter. Woodline Partners LP increased its position in shares of Corteva by 40.3% during the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after purchasing an additional 16,644 shares during the period. EverSource Wealth Advisors LLC raised its stake in shares of Corteva by 62.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock valued at $191,000 after purchasing an additional 980 shares in the last quarter. Cresset Asset Management LLC lifted its position in Corteva by 2.6% in the second quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after purchasing an additional 181 shares during the period. Finally, Jump Financial LLC bought a new stake in Corteva in the 2nd quarter valued at $1,464,000. Institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

NYSE CTVA opened at $78.82 on Thursday. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $90.97. The company has a 50 day moving average of $82.03 and a 200-day moving average of $79.79. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. The firm has a market cap of $52.59 billion, a price-to-earnings ratio of 52.20, a PEG ratio of 2.39 and a beta of 0.57.

Corteva (NYSE:CTVA) last announced its earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. During the same period in the previous year, the business earned $2.20 EPS. Corteva’s revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, equities analysts forecast that Corteva, Inc. will post 3.74 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be paid a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is 47.68%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the stock. BNP Paribas Exane increased their price objective on shares of Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. UBS Group upped their target price on shares of Corteva from $86.00 to $89.00 and gave the company a “neutral” rating in a research note on Monday. Barclays raised their price target on shares of Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a research note on Thursday, June 11th. Royal Bank Of Canada upped their price objective on Corteva from $97.00 to $103.00 and gave the company an “outperform” rating in a research note on Tuesday, July 21st. Finally, CICC Research raised their target price on Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $91.38.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.